Citalopram Hydrobromide
Product Images NDC 66116-352

2 FDA label images from Medvantx, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Citalopram Hydrobromide (NDC 66116-352). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medvantx, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Ab1bacf9 00fa 4332 8cb8 A5071b2a7723 01)

Structure (Ab1bacf9 00fa 4332 8cb8 A5071b2a7723 01)
Chemical structure of Citalopram Hydrobromide, showing its molecular arrangement including aromatic rings, a cyano group, a fluorine atom, and a dimethylaminoethyl side chain with a hydrobromide component.*
FDA Label Image

Citalopram 20mg Tablets #30 (Ab1bacf9 00fa 4332 8cb8 A5071b2a7723 02)

Citalopram 20mg Tablets #30 (Ab1bacf9 00fa 4332 8cb8 A5071b2a7723 02)
Label for Citalopram Tablets USP 20mg by MedVantx, Inc., containing 30 tablets. Instructions include dosage blanks for tablets per time, frequency, and days. Manufacturer noted as Dr. Reddy's Labs Ltd., India. Storage instructions specify controlled room temperature and keeping container closed. Label states 'Sample Only-Not for Sale' and includes a MedVantx help line phone number.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.